CJC-1295 + Ipamorelin Stack Injection Guide
CJC-1295 + Ipamorelin
Subcutaneous Injection - A synergistic combination of a GHRH analog (CJC-1295) and a GHRP mimetic (Ipamorelin). Together they stimulate natural growth hormone (GH) secretion through complementary mechanisms: GHRH releases stored GH, while GHRP triggers additional GH release for a potent, multi-directional GH-boosting effect.
Potential Benefits
Key advantages and therapeutic effects
Increased Growth Hormone Secretion
- GHRH + GHRP synergy amplifies GH pulse amplitude
- More pronounced and sustained GH elevation vs. single agents
- Stimulates endogenous GH production — not exogenous replacement
- Activates multiple GH-releasing pathways simultaneously
Muscle Growth & Protein Synthesis
- GH drives myofibrillar hypertrophy and muscle cell proliferation
- Enhanced amino acid uptake and nitrogen retention
- Improved post-workout recovery and reduced muscle breakdown (anti-catabolic)
- Synergistic effect when combined with resistance training
Fat Loss & Body Composition
- GH promotes lipolysis (fat breakdown) via hormone-sensitive lipase activation
- Increases fat oxidation, especially visceral fat
- Preserves lean muscle mass during caloric deficit
- Improves metabolic rate and glucose utilization
Enhanced Recovery & Sleep Quality
- GH is predominantly secreted during deep sleep — synergizes with sleep-dependent recovery
- Reduces muscle soreness and accelerates tissue repair
- May improve sleep architecture and time in restorative sleep stages
- Supports immune function via GH-mediated immune cell proliferation
Joint & Connective Tissue Health
- GH stimulates IGF-1 production in local tissues, promoting collagen synthesis
- Supports cartilage repair and synovial fluid production
- May reduce joint pain and inflammation
- Strengthens tendons and ligaments
Anti-Aging & Metabolic Benefits
- Improves skin elasticity and hydration (GH-mediated collagen turnover)
- Enhances insulin sensitivity and glucose metabolism
- May reduce markers of biological aging
- Supports bone density and mineralization
Endurance & Athletic Performance
- GH increases cardiac output and oxygen-carrying capacity
- Enhances VO2 max and aerobic performance
- Improves work capacity and training intensity tolerance
- Supports cardiovascular adaptation to endurance training
Injection Guide
Step-by-step subcutaneous administration
Gather Supplies
- CJC-1295 vial (typically 2mg)
- Ipamorelin vial (typically 5mg or powder form)
- Bacteriostatic water for injection
- Alcohol swabs
- 1cc insulin syringe
- 3cc syringe
- Sharps container
Wash Hands & Prepare Workspace
- Thoroughly wash your hands with soap and water.
- Prepare a clean, flat surface with alcohol swabs.
Reconstitute CJC-1295
- Using a 3cc syringe, draw 2mL of bacteriostatic water.
- Inject slowly into the CJC-1295 vial.
- Gently swirl for 20–30 seconds until fully dissolved — DO NOT SHAKE.
- Solution should be clear. Refrigerate after reconstitution (2–8°C).
Reconstitute Ipamorelin
- Using a fresh 3cc syringe, draw 3mL of bacteriostatic water.
- Inject slowly into the Ipamorelin vial.
- Gently swirl until fully dissolved — DO NOT SHAKE.
- Refrigerate after reconstitution (2–8°C).
Prepare Combined Dose
- Using a sterile insulin syringe, draw the CJC-1295 dose from its vial.
- In the SAME syringe, draw the Ipamorelin dose.
- The peptides are stable when mixed.
- Remove air bubbles by tapping and pushing the plunger slightly.
Choose Injection Site
- Abdomen (at least 2 inches away from the navel)
- Thighs (front or outer thigh)
- Back of the upper arm
- Rotate sites with each injection to minimize lipodystrophy
Clean the Site
- Wipe the injection site thoroughly with an alcohol swab.
- Allow 30 seconds for the site to air-dry completely.
Inject the Medication
- Pinch a fold of skin
- Insert the needle at a 45 to 90-degree angle.
- Push the plunger slowly over 10–15 seconds.
- Withdraw the needle and dispose in the sharps container.
- Apply light pressure with an alcohol swab.
- Do NOT rub the injection site — this increases absorption variability.
Injection Sites
Recommended locations for administration
ABDOMEN
Below ribs, above hip bones, at least 2 inches from navel. Excellent absorption and most common site for self-administration. Rotate between left and right sides.
THIGH
Front or outer thigh. Rotate between left and right thigh each session to prevent localized lipodystrophy (fat loss or buildup).
UPPER ARM
Back of the upper arm (triceps area). May be easier when administered by someone else; can be more difficult for self-injection.
Rotate injection sites each week to keep skin healthy and medication effective. Avoid areas that are scarred, bruised, or irritated.
Dosing Guide
Calculate your dose - consult your healthcare provider
Dosage Calculator
Calculate your insulin syringe units
Total peptide in vial
Amount of water added
Amount you want to inject
Draw this amount on your syringe:
Concentration: 15 mg/mL
This is for general educational purposes only — actual dosing should always be set by a licensed physician. Most protocols use a 1:1 molar ratio of CJC-1295 to Ipamorelin for optimal synergy. Common administration: morning injection upon waking (fasted) and/or pre-bedtime (2–3 hours after last meal). Best results when combined with proper sleep, nutrition, and resistance training. Typically used in 12-16 week cycles.
Suggested Dosage: CJC-1295 + Ipamorelin
General reference only. Consult your physician.
| Starting Dose | Typical Range | Upper-End / Max |
|---|---|---|
100 mcg each nightly | 200-300 mcg each | 500 mcg each 2x daily |
100 mcg each nightly
200-300 mcg each
500 mcg each 2x daily
This is for general educational purposes only — actual dosing should always be set by a licensed physician. Most protocols use a 1:1 molar ratio of CJC-1295 to Ipamorelin for optimal synergy. Common administration: morning injection upon waking (fasted) and/or pre-bedtime (2–3 hours after last meal). Best results when combined with proper sleep, nutrition, and resistance training. Typically used in 12-16 week cycles.
Side Effects
Potential adverse reactions to be aware of
Potential Side Effects
- Injection site redness or mild irritation
- Mild water retention (GH-related — usually transient)
- Transient hyperglycemia or altered glucose homeostasis
- Nausea or mild GI discomfort (especially post-injection on empty stomach)
- Headache or dizziness (rare)
- Carpel tunnel-like symptoms (rare, usually dose-dependent)
Cycle Information
Recommended timing between cycles
12-16 WEEKS ON, 4-6 WEEKS OFF
(Cycle & Recovery)